United Kingdom · Series A startup

Who invested in Biorelate

3 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Big Data & Analytics

Raised 2 months ago

Funding summaryUpdated 26 Oct 2026

$15Mraised across 3 rounds since 2022, from 3 sources

$7.8MSeries A$4.0MRound$3.5MRound
Latest round
Round, $3.5MAug 2026
Biggest round
$7.8MSeries A · Nov 2022
Investors
4
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2023202420252026
$7.8MSeries A$4.0MRound$3.5MRound
First round
Series A, $7.8M
Nov 2022
Biggest round
$7.8M
Series A · Nov 2022
Usual gap between rounds
23 months
the median of 2

The rounds

  1. Aug 2026
    Round$3.5M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  2. Sept 2024
    Round$4.0M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  3. Nov 2022

Funding filed with regulators

Biorelate filed 3 raises, $17M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Aug 2026$3.5MUK share allotment
  2. Sept 2024$4.0MUK share allotment
  3. Nov 2022$9.2MUK share allotment

Founders and team

From Biorelate's own website: 1 founder, 6 on the team.

Daniel JamiesonCEO & Founder, Biorelate
  • Bronwyn MurrayVice President of Finance
  • Katie BrownridgeVice President of Operations
  • Robert CorreaVice President of Sales
  • Tom ToddVice President of Technology
  • Ben SiddersChief Scientific Officer
  • Jason C. FosterLead Director, Biorelate

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Maven Capital PartnersPrivate equity1round
Triple Point VenturesAsset manager1round
YFM Equity PartnersPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Biorelate

Who invested in Biorelate?

Biorelate's investors include Maven Capital Partners, Triple Point Ventures, YFM Equity Partners and Northern Powerhouse Investment Fund.

How much has Biorelate raised?

Biorelate has raised $15M across 3 rounds since 2022.

When did Biorelate last raise?

Biorelate's most recent round, $3.5M, was in Aug 2026.

What was Biorelate's biggest round?

Biorelate's largest round on record is $7.8M (Series A), in Nov 2022.

Who backed Biorelate first?

Biorelate's first round on record, in Nov 2022, was backed by Maven Capital Partners, Triple Point Ventures and YFM Equity Partners and 1 others.

What stage is Biorelate at?

Biorelate's latest named round is a Series A, in Nov 2022.

Where is Biorelate based?

Biorelate is based in the United Kingdom.

Companies like Biorelate

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.